Clinical Laserthermia Systems Stock Current Valuation
| CLS-B Stock | SEK 4.36 0.14 3.11% |
Valuation analysis of Clinical Laserthermia helps investors to measure Clinical Laserthermia's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Clinical Laserthermia's price fluctuation is risky at this time. Calculation of the real value of Clinical Laserthermia is based on 3 months time horizon. Increasing Clinical Laserthermia's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Clinical stock is determined by what a typical buyer is willing to pay for full or partial control of Clinical Laserthermia Systems. Since Clinical Laserthermia is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Clinical Stock. However, Clinical Laserthermia's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.36 | Real 4.02 | Hype 4.5 | Naive 4.48 |
The intrinsic value of Clinical Laserthermia's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Clinical Laserthermia's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Clinical Laserthermia Systems helps investors to forecast how Clinical stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Clinical Laserthermia more accurately as focusing exclusively on Clinical Laserthermia's fundamentals will not take into account other important factors: Clinical Laserthermia Systems Company Current Valuation Analysis
Clinical Laserthermia's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Clinical Laserthermia Current Valuation | 73.29 M |
Most of Clinical Laserthermia's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clinical Laserthermia Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Clinical Laserthermia Systems has a Current Valuation of 73.29 M. This is 99.49% lower than that of the Healthcare sector and 99.41% lower than that of the Medical Devices industry. The current valuation for all Sweden stocks is 99.56% higher than that of the company.
Clinical Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clinical Laserthermia's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clinical Laserthermia could also be used in its relative valuation, which is a method of valuing Clinical Laserthermia by comparing valuation metrics of similar companies.Clinical Laserthermia is currently under evaluation in current valuation category among its peers.
Clinical Fundamentals
| Return On Equity | -2.59 | |||
| Return On Asset | -0.66 | |||
| Operating Margin | (23.95) % | |||
| Current Valuation | 73.29 M | |||
| Shares Outstanding | 134.52 M | |||
| Shares Owned By Insiders | 9.70 % | |||
| Shares Owned By Institutions | 2.27 % | |||
| Price To Earning | (10.13) X | |||
| Price To Book | 4.26 X | |||
| Price To Sales | 28.92 X | |||
| Revenue | 2.25 M | |||
| Gross Profit | (3.63 M) | |||
| EBITDA | (54.42 M) | |||
| Net Income | (63.62 M) | |||
| Cash And Equivalents | 13.5 M | |||
| Cash Per Share | 0.39 X | |||
| Total Debt | 100 K | |||
| Debt To Equity | 3.20 % | |||
| Current Ratio | 3.61 X | |||
| Book Value Per Share | 0.18 X | |||
| Cash Flow From Operations | (66.17 M) | |||
| Earnings Per Share | (1.08) X | |||
| Target Price | 1.4 | |||
| Number Of Employees | 12 | |||
| Beta | 0.78 | |||
| Market Capitalization | 104.76 M | |||
| Total Asset | 66.74 M | |||
| Retained Earnings | (88 M) | |||
| Working Capital | 14 M | |||
| Current Asset | 22 M | |||
| Current Liabilities | 8 M | |||
| Net Asset | 66.74 M |
About Clinical Laserthermia Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clinical Laserthermia Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clinical Laserthermia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clinical Laserthermia Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clinical Stock Analysis
When running Clinical Laserthermia's price analysis, check to measure Clinical Laserthermia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinical Laserthermia is operating at the current time. Most of Clinical Laserthermia's value examination focuses on studying past and present price action to predict the probability of Clinical Laserthermia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinical Laserthermia's price. Additionally, you may evaluate how the addition of Clinical Laserthermia to your portfolios can decrease your overall portfolio volatility.